Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia.
Abaza Y, Kantarjian H, Alwash Y, Borthakur G, Champlin R, Kadia T, Garcia-Manero G, Daver N, Ravandi F, Verstovsek S, Burger J, Estrov Z, Ohanian M, Lim M, Pemmaraju N, Jabbour E, Cortes J.
Abaza Y, et al. Among authors: pemmaraju n.
Am J Hematol. 2020 Nov;95(11):1288-1295. doi: 10.1002/ajh.25939. Epub 2020 Aug 12.
Am J Hematol. 2020.
PMID: 32681739
Free article.
Clinical Trial.